ada standards of care 2025 obesity pharmacotherapy glp-1 recommendations The pharmacological management Type 2 Diabetes, adapted from guidelines, focusing on treatment initiation and intensification based on patient comorbidities and glycemic control: Comprehensive Obesity Care, Not Just

A must-try for taste and support!

Minimizing side effects like stomach upset means focusing on nutrient-rich, easily digestible meals

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. | The demand for weight loss drugs is not slowing down, and many organizations voiced concerns there will likely be semaglutide shortages in the future that will impact patients' access to weight loss medications.

The more you know about these lesions, the easier itll be to treat them and prevent outbreaks

Discover GLP-1 for weight management at Synergy Face + Body by Travis Shaw MD in Richmond and Midlothian